Microfilament Actin Remodeling as a Potential Target for Cancer Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1873-5576|4|4|345-354

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.4, Iss.4, 2004-06, pp. : 345-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CDK9 a Potential Target for Drug Development

By  

Medicinal Chemistry, Vol. 4, Iss. 3, 2008-05 ,pp. : 210-218

Bentham Science Publishers

Access to resources Recommend Favorite

Drug-Target Pharmacogenomics: The potential to revolutionize drug discovery and development

By  

Pharmaceutical Innovation, Vol. 11, Iss. 4, 2002-06 ,pp. : 30-37

Adis International

Access to resources Recommend Favorite

G-quadruplex DNA: a potential target for anti-cancer drug design

By Han H.   Hurley L.H.  

Trends in Pharmacological Sciences, Vol. 21, Iss. 4, 2000-04 ,pp. : 136-142

Elsevier

Access to resources Recommend Favorite

The Role of YY1 in Oncogenesis and Its Potential as a Drug Target in Cancer Therapies

By  

Current Cancer Drug Targets, Vol. 15, Iss. 2, 2015-02 ,pp. : 145-157

Bentham Science Publishers

Access to resources Recommend Favorite

The Tumor Stroma as Mediator of Drug Resistance - A Potential Target to Improve Cancer Therapy?

By  

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 11, 2012-09 ,pp. : 2259-2272

Bentham Science Publishers

Access to resources Recommend Favorite